Congress questions Cardinal Health, other drug makers on opioid settlement tax breaks

Congress questions Cardinal Health, other drug makers on opioid settlement tax breaks

The Washington Post | Finanzas, Legal | Administración Pública, Farmacia |

Leer noticia completa en el medio original
Spanish